more likely to have received a third-trimester ultrasound (93.0% vs 40.3%, p<0.0001). Women with undetected FGR were also significantly more likely to have had a reassuring ultrasound with an EFW or AC >10 th centile (77.1% vs. 16.0%, p<0.0001).
THE EVIDENCE GAP IN THE PRACTICE OF BAKRI BALLOON TAMPONADE: LESSONS FROM A LARGE RETROSPECTIVE CASE SERIES AT A MAJOR TERTIARY CENTRE
Uterine balloon tamponade has emerged as a fertility-sparing and life-saving second line treatment option in postpartum haemorrhage (PPH). Despite the development of the Bakri balloon in the late 1990s, there is no robust evidence instructing its use or proving its efficacy. By conducting the largest retrospective case review and audit of Bakri balloon tamponade, we aim to provide an evidence base for future protocol and guideline development on its use.
Methods: The medical records of over 300 women who underwent Bakri balloon insertion at King Edward Memorial Hospital (Western Australia) between 2012 and 2017 were accessed and data manually recorded in a pre-determined data set. Descriptive statistics and subgroup comparisons will be used to analyse the case series data.
Results: Preliminary results from a sample of 108 of these patients so far indicate a 92% success rate for Bakri balloon use in PPH, duration of successful tamponade ranging from 7 to 33.5 hours, and not one case requiring return to theatre for further intervention once balloon tamponade was deemed successful at 4 hours following insertion.
Conclusions: Anticipated outcomes, once the analysis of the full sample is undertaken, would provide the needed evidence to improve practice such that the duration of tamponade is not required to exceed 7 hours, fasting for removal of the Bakri balloon is superfluous as not one case of successful Bakri balloon tamponade at 4 hours required return to theatre once removed, and that complication rates with use of Bakri balloon for PPH are negligible. Methods: Retrospective review of the PAL database from December 2015 to December 2016. The primary outcome measure; time till birth was categorised into three time periods, against the reported use of biochemical predictive tests and maternity service capability level.
THREATENED PRETERM LABOUR: AN AUDIT OF TWELVE MONTHS OF CALLS TO THE NSW AND ACT
Results: PAL co-ordinated 492 calls leading to 339 (69%) inutero transfers over 12 months. 167 (34%) of calls were for threatened preterm labour (TPL) and 24 (74%) of these were transferred. The mean gestational age at transfer was 30.1 weeks. Only 21 (17%) of women birthed within a week, and 93 (75%) did not birth within a week. Predictive biochemical testing was performed in only 84 (50%) cases with TPL, and most women did not birth within a week of transfer. Biochemical predictive testing was only used in 35% of the cases where women were transferred between level 6 facilities.
Conclusions: This study highlights the need to review current practices with the aim of reducing unnecessary intervention, admission and transfer rates of women with TPL. Reasons for the inconsistent use of predictive testing to be explored in order to best allocate resources and minimise patient dislocation.
MEASUREMENT OF RESPIRATION RATE IN PRETERM INFANTS USING A CONTACTLESS VISION-BASED SYSTEM
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